PD-1 is abundantly expressed on activated NK cells, and upon ligation with the PD-L1 receptor overexpressed in tumor cells, leads to immunosuppression, thereby impairing NK cell functionality [134]. The gene discussed is PDCD1; the disease is neoplasm.